PharmaDiversityJobBoard-Diversity Job Board connecting diversity & minority job seekers with Pharmaceutical jobs. Amerisource Bergen Jobs (ABC)
  Home  |  Login  |  Job Seeker Register  |  Employer Register    You're not logged in!
Translate:

Boehringer Ingelheim Jobs

 
Click links to read Current News for this Featured Employer    Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes | Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes | Boehringer Ingelheim Comments on June 18th FDA Advisory Committee Meeting | -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes | Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010 | Boehringer Ingelheim to Present New Data Regarding Its Investigational Compound BIBW 2992 in Head and Neck Cancer and Non-Small Cell Lung Cancer | Boehringer Ingelheim Announces New Data on Flibanserin in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder | Boehringer Ingelheim and Micromet Announce Global Collaboration for Multiple Myeloma BiTE Antibody | Boehringer Ingelheim's Pradaxa Will Garner Blockbuster Sales of $1.3 Billion by 2018 in the Atrial Fibrillation Drug Market | New Research Shows Emotional Impact of Low Sexual Desire and Associated Distress on Women | Boehringer Ingelheim's Pramipexole ER Will Garner Peak Year Sales of $250 to $500 Million for the Treatment of Parkinson's Disease | Boehringer Ingelheim Announces Pivotal Phase III Data of Flibanserin in Pre-Menopausal Women with Hypoactive Sexual Desire Disorder | Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer Acquisition positions Boehringer Ingelheim among the world's top animal health companies. | Allscripts and Sandata Partner to Enhance Quality in Home Care Agencies Nationwide Santrax Telephony Selected by Allscripts to Track Agency Staff and Ensure Compliance with Patient Care Plans | Boehringer Ingelheim's Diabetes Pipeline Continues to Advance as the Company Announces Conclusion of Robust Phase III Clinical Program for linagliptin Phase III data slated for presentation at international scientific congresses in 2010 | Boehringer Ingelheim Animal Health Enters into Agreement to Acquire Certain Assets of Fort Dodge Animal Health from Pfizer Acquisition will strengthen Boehringer Ingelheim's position as a vaccine supplier among the world's top animal health companies | Boehringer Ingelheim's Swiss Branch Improves Sales Reporting and Efficiency with MicroStrategy Software | Boehringer Ingelheim to Commence Phase III Study Investigating the Role of BIBW 2992 as First-Line Treatment for Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Mutations Data from Phase II studies investigating BIBW 2992 and BIBF 1120 in NSCLC patients presented at 13th World Conference on Lung Cancer (WCLC) | Boehringer Ingelheim Unveils Diabetes Pipeline New data presented at ADA demonstrate significant decrease in blood sugar levels with linagliptin added to metformin | Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 | Parkinson's Disease Community Unites to Find a Cure at the 15th Annual Parkinson's Unity Walk | Boehringer Ingelheim Recognized For Diversity And Inclusion Efforts | Mobile Dog Heart Health Tour Through California Cities to Provide Free Heart Examinations in Sound-Proof Setting | Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date | Bedford Laboratories(TM) to Begin Shipping Sumatriptan Succinate Injection | Break-through Drug for Heart Failure in Dogs Now Available in the United States | Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection | Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines | Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) | Large-Scale Survey Reveals Low Sexual Desire Most Common Distressing Female Sexual Problem, Affecting Up to One in 10 Women | New Survey Uncovers Critical Need for Education on Key Issues in Parkinson?s Disease Management | The Restless Legs Syndrome Foundation and National Sleep Foundation Give a Face - and a Voice - to Restless Legs Syndrome (RLS) |
 
  
Items 1-25/246 displayed. [1-25][26-50][51-75][76-100][101-125][126-150][151-175][176-200][201-225][226-246] next
SaveDateJob TitleCity CountryStateCompany NamePay
Jul 31 Team Leader, Security and Site Services
Manufacturing/Operations/Production		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Technician, NonSolids
Manufacturing/Operations/Production		 Fort Dodge Iowa  Boehringer Ingelheim Not specified
Jul 31 Technician - 2nd Shift M-F, Flow 6 Oak Street
Operations		 Columbus Ohio  Boehringer Ingelheim Not specified
Jul 31 VETERINARIAN, COMPANION ANIMAL TECHNICAL SERVICES
Marketing		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Technician IV, FD Calibration Group
Engineering/Site Services		 Fort Dodge Iowa  Boehringer Ingelheim Not specified
Jul 31 Technician - 2nd Shift M-F - Flow 2
Operations		 Columbus Ohio  Boehringer Ingelheim Not specified
Jul 31 Veterinarian, Technical Services
Marketing		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Trainer, Pet Products
Marketing		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Validation Specialist
Validations		 Fort Dodge Iowa  Boehringer Ingelheim Not specified
Jul 31 Technical Marketing Manager
Marketing		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Technician - 2nd Shift M-F - Flow 2
Operations		 Columbus Ohio  Boehringer Ingelheim Not specified
Jul 31 Technician - 3rd Shift M-F - Flow 2
Operations		 Columbus Ohio  Boehringer Ingelheim Not specified
Jul 31 Specialty Sales Representative Cardiology, Akron/Canton/Youngstown, OH
Sales		 Canton Ohio  Boehringer Ingelheim Not specified
Jul 31 Specialty Sales Representative Cardiology, Cleveland, OH
Sales		 Cleveland Ohio  Boehringer Ingelheim Not specified
Jul 31 Specialty Sales Representative Neurology - Cleveland, OH
Sales		 Cleveland Ohio  Boehringer Ingelheim Not specified
Jul 31 Strategic Sourcing Manager, Direct Materials
Purchasing		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Sr. Principal Software/Knowledge Engineer
Information Technology		 Ridgefield Connecticut  Boehringer Ingelheim Not specified
Jul 31 Sr. Principal Software Engineer, Document Management
Information Technology		 Ridgefield Connecticut  Boehringer Ingelheim Not specified
Jul 31 Sr. Scientist, Process Development
Science/Research & Development		 Fort Dodge Iowa  Boehringer Ingelheim Not specified
Jul 31 Sr. Associate Director, Medical Marketing Liaison
Clinical Research (Medicine & DRA)		 Ridgefield Connecticut  Boehringer Ingelheim Not specified
Jul 31 Supervisor, Quality Control Microbiology
Science/Research & Development		 Bedford Ohio  Boehringer Ingelheim Not specified
Jul 31 Supervisor, Process Validation
Validations		 Bedford Ohio  Boehringer Ingelheim Not specified
Jul 31 Specialist, Pharmacovigilance
Quality		 St. Joseph Missouri  Boehringer Ingelheim Not specified
Jul 31 Specialty Sales Representative Cardiology,Indiana South
Sales		 BLOOMINGTON Indiana  Boehringer Ingelheim Not specified
Jul 31 Sr. Principal Business Analyst, Legal Litigation
Information Technology		 Ridgefield Connecticut  Boehringer Ingelheim Not specified